C. Evan Ballantyne's most recent trade in Gain Therapeutics Inc was a trade of 100,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on April 10, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gain Therapeutics Inc | C. Evan Ballantyne | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2023 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Gain Therapeutics Inc | C. Evan Ballantyne | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2023 | 50,000 | 50,000 | - | - | Restricted Stock Units |